(Q73309123)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11121910%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

title

5-day vs. 7-day triple therapy with rabeprazole, clarithromycin and amoxicillin for Helicobacter pylori eradication (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11121910%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

1 reference

1 reference

1 reference

Helicobacter pylori infectious disease

1 reference

H Isomoto

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11121910%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

H Furusu

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11121910%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

T Morikawa

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11121910%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

Y Mizuta

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11121910%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

T Nishiyama

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11121910%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

K Omagari

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11121910%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

K Murase

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11121910%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

K Inoue

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11121910%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

I Murata

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11121910%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

S Kohno

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11121910%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

publication date

1 December 2000

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11121910%20AND%20SRC:MED&resulttype=core&format=json

Alimentary Pharmacology & Therapeutics

2 November 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11121910%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

volume

14

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11121910%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

issue

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11121910%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

page(s)

1619-1623

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11121910%20AND%20SRC:MED&resulttype=core&format=json

Helicobacter pylori and the pathogenesis of gastroduodenal inflammation

2 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2000.00892.X

Effect of triple therapy (antibiotics plus bismuth) on duodenal ulcer healing. A randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2000.00892.X

Lansoprazole triple therapy for Helicobacter pylori--is 5 days enough?

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2000.00892.X

Safety and efficacy of rabeprazole in combination with four antibiotic regimens for the eradication of Helicobacter pylori in patients with chronic gastritis with or without peptic ulceration.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2000.00892.X

Impact of rabeprazole, a new proton pump inhibitor, in triple therapy for Helicobacter pylori infection-comparison with omeprazole and lansoprazole.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2000.00892.X

Efficacy of reduced dosage of rabeprazole in PPI/AC therapy for Helicobacter pylori infection: comparison of 20 and 40 mg rabeprazole with 60 mg lansoprazole

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2000.00892.X

Kinetic studies of Helicobacter pylori urease inhibition by a novel proton pump inhibitor, rabeprazole.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2000.00892.X

Review article: the pharmacology of rabeprazole

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2000.00892.X

In vitro activities of rabeprazole, a novel proton pump inhibitor, and its thioether derivative alone and in combination with other antimicrobials against recent clinical isolates of Helicobacter pylori

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2000.00892.X

Amoxicillin/metronidazole/omeprazole/clarithromycin: a new, short quadruple therapy for Helicobacter pylori eradication

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2000.00892.X

Resistance of Helicobacter pylori to antibiotics

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2000.00892.X

10.1046/J.1365-2036.2000.00892.X

21 January 2018

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11121910%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

1 reference